Establishment of a Network Platform for Fertility-sparing in Patients With Endometrial Cancer and Study on Fertility-sparing Therapy for Patients With Stage IA Endometrial Cancer.
The goal of this clinical trial is to explore the feasibility and outcome of fertility-sparing therapy in Stage IA G1-G2 Endometrial Cancer with less than 1/2 myometrial invasion. Researchers will render participants indication-extended fertility-sparing therapy. Researchers will compare the myometrial invasion group with the no myometrial invasion group to see if it is possible to propose an extension indication of fertility-sparing therapy for endometrial cancer.
• Stage IA (FIGO 2009) ;
• Pathological diagnosis: endometrial adenocarcinoma G1-G2;
• MRI or ultrasound: tumor limited to endometrium or invading less than 1/2 of myometrium；
• 18 years old ≤ Age ≤ 45 years old;
• With a strong desire for fertility preservation；
• Sign the informed consent.